# Christopher P. Cannon

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christopher-p-cannon/

## Facts

| Field | Value |
| --- | --- |
| Citations | 113,073 |
| Field | Acute Myocardial Infarction Research |
| h-index | 156 |
| i10-index | 714 |
| Last Known Institution | Brigham and Women's Hospital |
| OpenAlex ID | https://openalex.org/A5026602252 |
| ORCID iD | 0000-0003-4596-2791 |
| Works | 1,345 |

## Researcher papers

Showing 12 of 28.

- [Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy](https://scholariq.org/papers/canagliflozin-and-renal-outcomes-in-type-2-diabetes-and-nephropathy/)
- [Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes](https://scholariq.org/papers/intensive-versus-moderate-lipid-lowering-with-statins-after-acute-coronary/)
- [Third universal definition of myocardial infarction](https://scholariq.org/papers/third-universal-definition-of-myocardial-infarction-3/)
- [Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes](https://scholariq.org/papers/alogliptin-after-acute-coronary-syndrome-in-patients-with-type-2-diabetes/)
- [C-Reactive Protein Levels and Outcomes after Statin Therapy](https://scholariq.org/papers/c-reactive-protein-levels-and-outcomes-after-statin-therapy/)
- [Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban](https://scholariq.org/papers/comparison-of-early-invasive-and-conservative-strategies-in-patients-with/)
- [TIMI Frame Count](https://scholariq.org/papers/timi-frame-count/)
- [Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure](https://scholariq.org/papers/sotagliflozin-in-patients-with-diabetes-and-recent-worsening-heart-failure/)
- [Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes](https://scholariq.org/papers/cardiac-specific-troponin-i-levels-to-predict-the-risk-of-mortality-in-patients/)
- [Acute myocardial infarction](https://scholariq.org/papers/acute-myocardial-infarction/)
- [Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes](https://scholariq.org/papers/cardiovascular-outcomes-with-ertugliflozin-in-type-2-diabetes/)
- [Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation](https://scholariq.org/papers/dual-antithrombotic-therapy-with-dabigatran-after-pci-in-atrial-fibrillation/)

## Researcher topics

- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [Brigham and Women's Hospital](https://scholariq.org/institutions/brigham-and-women-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.